News
Filters
Showing 11 - 14 out of 14 results
Article
Witnessing a breakthrough: physicians find hope in new Alzheimer’s drug
For neurologists working with patients with Alzheimer’s disease, the road to actual treatment options has been long and paved with setbacks.
But that is changing for some patients. The Food and Drug Administration recently granted full approval to Leqembi® (lecanemab), the first disease-modifying treatment fully approved for patients in the early stages of Alzheimer’s disease. The development of this new drug offers hope to patients and may have lasting impacts on how physicians approach treatment.
News
Missouri Baptist Medical Center Mammography Van Provides Breast Health Screenings
Article
Noticing the Signs and Symptoms of Stroke Can Help Save a Life
Patient Story